Compare Prologis Inc (PLD) vs uniQure N.V. Ordinary Shares (QURE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Prologis Inc vs uniQure N.V. Ordinary Shares — how do they compare? Prologis Inc trades at $130.22 (market cap $123.98B), while uniQure N.V. Ordinary Shares trades at $20.67 (market cap $1.45B). The key difference: Prologis Inc is far larger — about 85.5× uniQure N.V. Ordinary Shares's market cap, and Prologis Inc pays a 3.28% dividend while uniQure N.V. Ordinary Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold Prologis Inc for 102 Days and uniQure N.V. Ordinary Shares for 0 Days on average.
| PLD | QURE | |
|---|---|---|
Market Cap | $123.98B | $1.45B |
Volume | 6,440,322 | 3,323,243 |
Sector | Real Estate | Health |
52-Week High | $149.96 | $70.59 |
52-Week Low | $121.17 | $9.03 |
Typical Hold Time | 102 Days | 0 Days |
Enterprise Value | $158.72B | $707.46M |
Dividend Yield | 3.28% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Prologis (PLD) trades at $133.55, up 0.82% with strong earnings momentum after beating estimates for three consecutive quarters. The stock shows bullish technical signals with support at $130 and resistance at $134. Fundamentals remain solid with 45.79% net income margin and robust cash flow generation, though valuation multiples appear elevated at P/E 29.74 and P/S 13.92. Recent news highlights accelerating warehouse demand from e-commerce and data centers.
Outlook remains positive with analyst consensus target of $155.15 (16% upside) and 62% buy ratings. Key opportunities include data center expansion and leasing growth, while risks involve premium valuation sensitivity and rising debt levels. The company's strategic positioning in logistics real estate supports long-term growth prospects despite near-term market volatility.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Prologis Inc
Prologis was formed by the June 2011 merger of AMB Property and Prologis Trust. The company develops, acquires, and operates around 1 billion square feet of high-quality industrial and logistics facilities across the globe. The company also has a strategic capital business segment that has around $70 billion of third-party AUM. The company is organized into four global divisions (Americas, Europe, Asia, and other Americas) and operates as a real estate investment trust.
Read more on PLD →About uniQure N.V. Ordinary Shares
uniQure N.V. is a biotechnology company that develops gene therapies for rare and severe genetic diseases, marketing HEMGENIX for hemophilia B and advancing its AAV-based miQURE platform in programs such as AMT-130 for Huntington's disease.
Read more on QURE →
